Results 81 to 90 of about 4,397,412 (173)

Short-Term correlation of the psoriasis area severity index, the nail psoriasis area severity index, and the dermatology life quality index, before and after treatment, in patients with skin and nail psoriasis

, 2019
Background: The response to treatment in patients suffering from skin and nail psoriasis is quantitatively evaluated by monitoring clinical severity and quality of life indexes, especially in the context of clinical trials. Among them, the psoriasis area
Rigopoulos, D., Prevezas, C., Katoulis, A.C., Panagakis, P., Papadavid, E.   +4 more
core   +1 more source

Efficacy of Intralesional Methotrexate Injection versus Triamcinolone Acetonide in Nail Psoriasis: A-Systematic Review and Meta-Analysis

Dermatology Practical & Conceptual
Introducion: Psoriasis is a chronic inflammatory skin disease that can affect many parts of the body. Psoriatic involvement of the nail bed or nail matrix results in nail psoriasis that is common.
Stephanie Nathania, Diah Adriani Malik, Muslimin, Hardian   +3 more
doaj   +1 more source

Enzymatic Synthesis of a Novel α‐Linolenic Acid‐Enriched Phytoceramide From Perilla Seed Oil and Its Multifunctional Bioactivity in Skin Barrier Repair and Anti‐Aging

Chemistry &Biodiversity, Volume 23, Issue 10, October 2026.
An enzymatically synthesized α‐linolenic acid‐enriched phytoceramide from perilla seed oil (PSO) is presented. This novel ceramide demonstrates potent activation of skin barrier genes in keratinocytes and protection against UVB‐induced extracellular matrix (ECM) degradation in fibroblasts.
Jumao Yuan, Ning Hao, Borui Shi, Zhenzhen Wang, Jie Yu, Nuo Shi, Lin Lin   +6 more
wiley   +1 more source

Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort

Frontiers in Immunology
ObjectiveTo compare the real-world clinical efficacy and safety of interleukin (IL)-17A inhibitors (secukinumab [SEC] and ixekizumab [IXE]) versus the IL-23 inhibitor guselkumab (GUS) in patients with nail psoriasis, with a focus on site-specific ...
Xiamei Yan, Xiamei Yan, Minglan Shi, Bin Wang, Lihua Zeng, Huiwei Wang, Jialiang Shi, Yaqian Cui, Suchun Hou   +8 more
doaj   +1 more source

Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nina Matthes, Julian Kött, Finn Abeck, Inga Hansen‐Abeck, Jana Bertels, Nina Booken, Stefan W. Schneider   +6 more
wiley   +1 more source

Receptor‐Targeted Niosomal Nanocarriers: Advances, Challenges, and Opportunities in Natural Compound Delivery for Cancer Therapy

Nano Select, Volume 7, Issue 10, October 2026.
Surface‐modified niosomes are introduced as multifunctional nanoparticles for precision tumor treatment that combine hydrophilic and lipophilic drug encapsulation with ligand‐based targeting via antibodies, peptides, transferrin, and folic acid. This modification leads to increased tumor selectivity, facilitates cell entry, and enables enhanced ...
Narges Sahraei, Aryan M. Faraj, Faezeh Molaei, Abolfazl Barzegar   +3 more
wiley   +1 more source

Assessment of Major Adverse Cardiovascular Event Across Diverse Racial Groups of Psoriasis Patients on Biologic Therapy: A Retrospective Cohort Study

The Journal of Dermatology, Volume 53, Issue 10, Page 1439-1447, October 2026.
ABSTRACT Psoriasis is associated with an increased risk of major adverse cardiovascular events (MACE), and biologic therapy may reduce this risk by targeting systemic inflammation. However, limited data exist on whether long term MACE risk differs by biologic class or across racial groups. We conducted a retrospective cohort study to assess the risk of
Chunghwan Ro, Ana Ormaza Vera, Waleed Adawi, Clinton W. Enos   +3 more
wiley   +1 more source

Optimal management of nail disease in patients with psoriasis

, 2015
Bianca Maria Piraccini, Michela Starace Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy Abstract: Psoriasis is a common skin disease, with nail involvement in approximately 80%
Piraccini BM, PIRACCINI, BIANCA MARIA, STARACE, MICHELA, Starace M   +3 more
core  

Antifungal Dispensing in Denmark: Patterns Across Primary Care, Secondary Care, and Over‐the‐Counter Sectors

APMIS, Volume 134, Issue 10, October 2026.
ABSTRACT Fungal infections pose a significant health burden in Denmark. Increasing global antifungal use and emerging antifungal resistance underscore the need for ongoing characterization of national prescribing trends to inform antifungal stewardship.
Aditya K. Gupta, Elizabeth M. Teasell, Gregory Pellegrino, Vasiliki Economopoulos, Ditte M. L. Saunte   +4 more
wiley   +1 more source

Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis

Psoriasis: Targets and Therapy, 2018
Florian Anzengruber,1,2 Adhideb Ghosh,1–3 Julia-Tatjana Maul,1,2 Mathias Drach,1,2 Alexander A Navarini1–3 1Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; 2Faculty of Medicine, University of Zurich, Zurich ...
Anzengruber F, Ghosh A, Maul JT, Drach M, Navarini AA   +4 more
doaj